The ADAG is composed of drug discovery experts from both industry and academia, based in the UK and beyond, and participates in the annual reviews of ARUK’s Drug Discovery institutes, who together form the ARUK Drug Discovery Alliance.

  • Chair – Dr Michael J. O’Neill, AbbVie – Senior Director of Drug Discovery Biology
  • Dr Ian Waddell, Charles River Laboratories – Executive Director, Biology (Europe)
  • Professor John Atack, University of Cardiff – Director, Medicines Discovery Institute
  • Dr Todd Golde, University of Florida – Director, McKnight Brain Institute; Director, 1Florida Alzheimer’s Disease Research Center
  • Dr Karl Gibson, Sandexis Medicinal Chemistry Ltd – Director
  • Dr Richard Mead, University of Sheffield - Senior Lecturer, Department of Neuroscience
  • Dr Jill Richardson, MSD – Senior Director, Discovery Research MRL UK
  • Dr John Kemp, Syndesi Therapeutics – Chief Scientific Officer